Heather J, Myers P, Shi F, Aziz Zanjani M, Mahoney K, Perez M, et al. Murine xenograft bioreactors for human immunopeptidome discovery. Sci Rep. 2019;9:18558 pubmed publisher

Brito G, Schormann W, Gidda S, Mullen R, Andrews D. Genome-wide analysis of Homo sapiens, Arabidopsis thaliana, and Saccharomyces cerevisiae reveals novel attributes of tail-anchored membrane proteins. BMC Genomics. 2019;20:835 pubmed publisher

Derr K, Zou J, Luo K, Song M, Sittampalam G, Zhou C, et al. Fully 3D Bioprinted Skin Equivalent Constructs with Validated Morphology and Barrier Function. Tissue Eng Part C Methods. 2019;: pubmed publisher

Musante I, Scudieri P, Venturini A, Guidone D, Caci E, Castellani S, et al. Peripheral localization of the epithelial sodium channel in the apical membrane of bronchial epithelial cells. Exp Physiol. 2019;104:866-875 pubmed publisher

Alghanem A, Wilkinson E, Emmett M, Aljasir M, Holmes K, Rothermel B, et al. RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells. Angiogenesis. 2017;20:341-358 pubmed publisher

Hashimoto S, Mikami S, Sugino H, Yoshikawa A, Hashimoto A, Onodera Y, et al. Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer. Nat Commun. 2016;7:10656 pubmed publisher

Perga S, Giuliano Albo A, Lis K, Minari N, Falvo S, Marnetto F, et al. Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. PLoS ONE. 2015;10:e0129291 pubmed publisher

Royston D. The current place of aprotinin in the management of bleeding. Anaesthesia. 2015;70 Suppl 1:46-9, e17 pubmed publisher

. Regulatory decisions pertaining to aprotinin may be putting patients at risk. CMAJ. 2014;186:1379-86 pubmed publisher

Weininger U, Modig K, Akke M. Ring flips revisited: (13)C relaxation dispersion measurements of aromatic side chain dynamics and activation barriers in basic pancreatic trypsin inhibitor. Biochemistry. 2014;53:4519-25 pubmed publisher

Leroux P, Omouendze P, Roy V, Dourmap N, Gonzalez B, Brasse Lagnel C, et al. Age-dependent neonatal intracerebral hemorrhage in plasminogen activator inhibitor 1 knockout mice. J Neuropathol Exp Neurol. 2014;73:387-402 pubmed publisher

Two A, Hata T, Nakatsuji T, Coda A, Kotol P, Wu W, et al. Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor. J Invest Dermatol. 2014;134:1143-1145 pubmed publisher

Sunyakumthorn P, Petchampai N, Grasperge B, Kearney M, Sonenshine D, Macaluso K. Gene expression of tissue-specific molecules in ex vivo Dermacentor variabilis (Acari: Ixodidae) during rickettsial exposure. J Med Entomol. 2013;50:1089-96 pubmed

Molnar T, Vörös J, Szeder B, Takáts K, Kardos J, Katona G, et al. Comparison of complexes formed by a crustacean and a vertebrate trypsin with bovine pancreatic trypsin inhibitor - the key to achieving extreme stability?. FEBS J. 2013;280:5750-63 pubmed publisher

Cheng A, Tsai I. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom. Biochim Biophys Acta. 2014;1840:153-9 pubmed publisher

Pagano D, Freemantle N. Reply to the editor. J Thorac Cardiovasc Surg. 2013;146:732 pubmed publisher

Catalá López F. Clinical evidence from randomized trials, network meta-analyses, and conflicts of interests. J Thorac Cardiovasc Surg. 2013;146:731-2 pubmed publisher

Kaya H, Kafali M, Aydin K, Kocak S, Sahin M, Duran A, et al. Efficacy of aprotinin treatment on bilateral blunt chest trauma created in rabbits. J Pak Med Assoc. 2013;63:32-7 pubmed

Walker A. Matching on provider is risky. J Clin Epidemiol. 2013;66:S65-8 pubmed publisher

Rosén M. EMA, transparency, and decision-making process. Lancet. 2013;382:26-7 pubmed publisher

Khan M, Islam M, Kuroda Y. Analysis of protein aggregation kinetics using short amino acid peptide tags. Biochim Biophys Acta. 2013;1834:2107-15 pubmed publisher

Ohnishi Y, Yamada T, Kurihara K, Tanaka I, Sakiyama F, Masaki T, et al. Neutron and X-ray crystallographic analysis of Achromobacter protease I at pD 8.0: protonation states and hydration structure in the free-form. Biochim Biophys Acta. 2013;1834:1642-7 pubmed publisher

Ortmann E, Besser M, Klein A. Antifibrinolytic agents in current anaesthetic practice. Br J Anaesth. 2013;111:549-63 pubmed publisher

McMullan V, Alston R. III. Aprotinin and cardiac surgery: a sorry tale of evidence misused. Br J Anaesth. 2013;110:675-8 pubmed publisher

Sathyamoorthy B, Singarapu K, Garcia A, Szyperski T. Protein conformational space populated in solution probed with aromatic residual dipolar (13) C-(1) H couplings. Chembiochem. 2013;14:684-8 pubmed publisher

Meybohm P, Herrmann E, Nierhoff J, Zacharowski K. Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patients. PLoS ONE. 2013;8:e58009 pubmed publisher

Roberts I, Shakur H, Ker K, Coats T. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2012;12:CD004896 pubmed

Millers E, Johnson L, Birrell G, Masci P, Lavin M, de Jersey J, et al. The structure of human microplasmin in complex with textilinin-1, an aprotinin-like inhibitor from the Australian brown snake. PLoS ONE. 2013;8:e54104 pubmed publisher

Later A, Sitniakowsky L, van Hilten J, van de Watering L, Brand A, Smit N, et al. Antifibrinolytics attenuate inflammatory gene expression after cardiac surgery. J Thorac Cardiovasc Surg. 2013;145:1611-6, 1616.e1-4 pubmed publisher

Tvarijonaviciute A, Martinez Subiela S, Ceron J. Influence of different storage conditions and anticoagulants on the measurement of total and acylated ghrelin in dogs: a preliminary study. Vet Rec. 2013;172:289 pubmed publisher

Catalá López F. Safety of aprotinin in adult cardiac surgery: revisiting the validity of a mixed-treatment comparison meta-analysis. J Thorac Cardiovasc Surg. 2013;145:610 pubmed publisher

Wan H, Lee K, Kim B, Zou F, Yoon H, Je Y, et al. A spider-derived Kunitz-type serine protease inhibitor that acts as a plasmin inhibitor and an elastase inhibitor. PLoS ONE. 2013;8:e53343 pubmed publisher

Matsuda T, Watanabe S, Kigawa T. Cell-free synthesis system suitable for disulfide-containing proteins. Biochem Biophys Res Commun. 2013;431:296-301 pubmed publisher

Glotzbach B, Schmelz S, Reinwarth M, Christmann A, Heinz D, Kolmar H. Structural characterization of Spinacia oleracea trypsin inhibitor III (SOTI-III). Acta Crystallogr D Biol Crystallogr. 2013;69:114-20 pubmed publisher

Dauter Z. Placement of molecules in (not out of) the cell. Acta Crystallogr D Biol Crystallogr. 2013;69:2-4 pubmed publisher

Reinwarth M, Glotzbach B, Tomaszowski M, Fabritz S, Avrutina O, Kolmar H. Oxidative folding of peptides with cystine-knot architectures: kinetic studies and optimization of folding conditions. Chembiochem. 2013;14:137-46 pubmed publisher

Bhunia B, Basak B, Mandal T, Bhattacharya P, Dey A. Effect of pH and temperature on stability and kinetics of novel extracellular serine alkaline protease (70 kDa). Int J Biol Macromol. 2013;54:1-8 pubmed publisher

Martin K, Gertler R, MacGuill M, Mayr N, Hapfelmeier A, Hörer J, et al. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. Br J Anaesth. 2013;110:615-21 pubmed publisher

Fan Y, Lin R, Yang L, Ye L, Yu J, Shu Q. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience. Paediatr Anaesth. 2013;23:242-9 pubmed publisher

Lecker I, Wang D, Romaschin A, Peterson M, Mazer C, Orser B. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest. 2012;122:4654-66 pubmed publisher

Later A, Bruggemans E, Romijn F, Van Pelt J, Klautz R. A comparative study of the immune modulating properties of antifibrinolytics in cardiac surgery. Cytokine. 2013;61:438-44 pubmed publisher

Ranasinghe S, McManus D. Structure and function of invertebrate Kunitz serine protease inhibitors. Dev Comp Immunol. 2013;39:219-27 pubmed publisher

Maruna P, Klein A, Kunstyr J, Plocová K, Mlejnsky F, Lindner J. Aprotinin reduces the procalcitonin rise associated with complex cardiac surgery and cardiopulmonary bypass. Physiol Res. 2013;62:27-33 pubmed

Fenley A, Muddana H, Gilson M. Entropy-enthalpy transduction caused by conformational shifts can obscure the forces driving protein-ligand binding. Proc Natl Acad Sci U S A. 2012;109:20006-11 pubmed publisher

Riddell R, Buth K, Sullivan J. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia. Can J Anaesth. 2013;60:16-23 pubmed publisher

Beckerman Z, Shopen Y, Alon H, Cohen O, Nir R, Adler Z, et al. Coronary artery bypass grafting after aprotinin: are we doing better?. J Thorac Cardiovasc Surg. 2013;145:243-8 pubmed publisher

Yang H, Wang Y, Xiao Y, Wang Y, Wu J, Liu C, et al. A bi-functional anti-thrombosis protein containing both direct-acting fibrin(ogen)olytic and plasminogen-activating activities. PLoS ONE. 2011;6:e17519 pubmed publisher

Mahdy A, Webster N. Perioperative systemic haemostatic agents. Br J Anaesth. 2004;93:842-58 pubmed

Mannucci P. Hemostatic drugs. N Engl J Med. 1998;339:245-53 pubmed